Skip to content

Comparative of the Effectiveness of Turmeric Extract with Mefenamic Acid on Pain Intensity of Primary Dysmenorrhea

Comparative of the Effectiveness of Turmeric Extract with Mefenamic Acid on Pain Intensity of Primary Dysmenorrhea

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160821029446N5
Enrollment
132
Registered
2018-06-20
Start date
2018-06-22
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Every participant will be randomly given 27 turmeric capsules for three consecutive cycles. After explaining how each drug is taken, (i.e. three capsules should be

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 28 Years

Inclusion criteria

Inclusion criteria: Being single Aged between 18-28 At least one semester has been left Having dysmenorrhea with the features of primary dysmenorrhea in most menstrual cycles in the last 6 months Having regular menstrual cycle (21-35 days) Not having female genital problems (ovarian cysts, fibroma, abnormal uterine bleeding) Absence of coagulation disorders Absence of abdominal and pelvic surgery history Absence of drug interaction such as glycemic control drugs and high blood pressure drugs Absence of allergy to turmeric and its compounds Absence of allergy to non-steroidal anti-inflammatory drugs Not using relaxation techniques over the last 6 months Absence of physical and mental illness Not participating in other studies

Exclusion criteria

Exclusion criteria: Unwillingness to continue the participation during the study for any reason Getting married during the study any Unmodified side effects

Design outcomes

Primary

MeasureTime frame
Dysmenorrhea intensity. Timepoint: In 2 control cycles and then after taking drugs In the form of three capsules every 8 hours for three days until 3 cycles. Method of measurement: verbal multidimensional scoring system.;Blood loss during menstrual cycle. Timepoint: In 2 control cycles and then after taking drugs In the form of three capsules every 8 hours for three days until 3 cycles. Method of measurement: Pictorial Blood Loss Assessment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Yazdi

Tehran University of Medical Sciences

yazdimaryam20@yahoo.com+98 21 2966 1717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026